Posts by AT_Management

Autism Therapeutics Featured in Neurotech Insights

Posted by on Dec 6, 2012 in Publications | 0 comments

Autism Therapeutics was featured in the December, 2012 Issue of Neurotech Insights (titled “Neuroregeneration”) published by NeuroInsights. Neurotech Insights is a source for competitive intelligence on the neurotechnology industry. Every monthly issue contains: Neurotech Market Activity Analysis Clinical Trials and Product News Alerts Recent Deals, Alliances, and Financings Stock Tracking and Performance Data Featured Company Profile Editorial Articles on Hot Topics Each issue includes an in-depth topic review.  Recent issues focused on sleep disorders, depression, multiple...

Read More

Introducing Autism Therapeutics

Posted by on Nov 27, 2012 in Splash Page | 0 comments

Introducing Autism Therapeutics

Autism Therapeutics is in the final stages of clinical development for a new drug which, if FDA approved, would provide treatment for the unmet medical need of autistic patients suffering with repetitive behaviors.    

Read More

Meeting Patient Needs

Posted by on Nov 20, 2012 in Splash Page | 0 comments

Meeting Patient Needs

There are currently no FDA approved treatments for a core symptom of autism and there remains a clear unmet medical need.

Read More

A Dynamic Approach to the Challenges of Clinical Development in Autism

Posted by on Nov 10, 2012 in Splash Page | 0 comments

A Dynamic Approach to the Challenges of Clinical Development in Autism

Autism Therapeutics views the heterogeneity in autism as a guiding principle rather than an impediment to precise and conscientious drug development.

Read More

A Leader In Autism

Posted by on Nov 5, 2012 in Splash Page | 0 comments

A Leader In Autism

Autism Therapeutics has pioneered new clinical trial design strategies aimed at addressing commonly confounding issues of heterogeneity in autism clinical trials.

Read More